Highlights

• Stock price indicates the company’s market value, but the price of a stock also depends on the number of shares outstanding.
• The highest share price does not always stay as stock markets are highly volatile in today’s world.
• Some of the most expensive companies on LSE are Personal Assets Trust PLC, Spirax-Sarco Engineering PLC, Ferguson PLC, Flutter Entertainment PLC, and AstraZeneca PLC.

The stock market is immense and growing investors having high risk appetite may consider investing in stocks and if you are a prudent investor you should invest in safe investment opportunities such as bonds and term deposits.

Stock price indicates the company’s market value, but the price of a stock also depend on the number of shares outstanding, as some stocks have a high price because the company never or rarely announces a stock split.  The prices of stock may not necessarily indicate its quality.

However, the highest share price does not always stay as the highest share price, as stock markets are highly volatile in today’s world.

Source: Copyright © 2021 Kalkine Media

So here, let us look at some of the current most expensive stocks listed on the London Stock Exchange. 

1. Personal Assets Trust PLC (LON: PNL)

The FTSE 250-listed Personal Assets Trust Plc is an investment trust run for private investors, who have committed to it a substantial proportion of their personal wealth.

Which are the Most Expensive Stocks in Recent Times

The company’s shares are trading at GBX 50,600, up by 0.40% in the early hours of trade at 8:00 AM on 18 November 2021. Its shares gave a return of 10.84% to shareholders in the last one year, and the market cap stood at £1,752 million. 

Also read: Should you hold on to these 5 hospitality stocks?                                                                                   

2. Spirax-Sarco Engineering PLC (LON:SPX)

The FTSE 100-listed Spirax-Sarco Engineering PLC is an industrial engineering company that manufactures steam management systems and peristaltic pumps and related fluid path technologies.

The company has reported increase in revenue by 13% for six month ended 30 June, to £643.7 million, as compared to £569.7 million for same period in 2020. It’s operating profit increased by 39%, to £153.6 million, as compared to £110.8 million for same period in 2020.

The company’s shares are trading at GBX 16,320, up by 0.96% in the early hours of trade at 8:00 AM on 18 November 2021. Its shares gave a return of 37.17% to shareholders in the last one year, and the market cap stood at £11,899.41 million. 

3. Ferguson PLC (LON: FERG)

The FTSE 100-listed Ferguson Plc is a multinational distributor of heating, plumbing, ventilating, air conditioning, waterworks, industrial fittings, and refrigeration (HVAC/R) products.

The company has reported increase in revenue by 14.3% for year ended 31 July 2021, to £22,792 million, as compared to £19,940 million for same period in 2020. It’s profit after tax increased by 46.4%, to £1,891 million, as compared to £1,292 million for same period in 2020.

The company’s shares are trading at GBX 12,050, up by 0.88% in the early hours of trade at 8:00 AM on 18 November 2021. Its shares gave a return of 50.26% to shareholders in the last one year, and the market cap stood at £26,444.25 million. 

Also read: UK announces plan to boost overseas trade, 5 stocks to buy now

4. Flutter Entertainment PLC (LON: FLTR)

The FTSE 100-listed Flutter Entertainment Plc is a global sport betting and gaming operator. It operates through four business segment that include Australia, US, Retail and Online. The company has recently acquired Tombola, one of the UK’s leading online bingo operators.

The company’s shares are trading at GBX 11,790, up by 0.86% in the early hours of trade at 8:00 AM on 18 November 2021. Its shares gave a return of -7.61% to shareholders in the last one year, and the market cap stood at £20,510.51 million. 

5. AstraZeneca PLC (LON: AZN)

The FTSE 100-listed AstraZeneca Plc is a UK-Based leading multinational biopharmaceutical company that is engaged in discovery, development, manufacturing and selling of biotechnology and pharma products.  The company was also one of the first few Covid-19 vaccine makers.

The company reported increase in its total revenue by 28% in YTD 2021 to US$ 25,406 million, as compared to US$19,207 million in YTD 2020. Its operating profit fell by 57%, to US$1,348 million, from US$3,675 million in YTD 2020. 

The company’s shares are trading at GBX 8,525, down by 0.76% in the early hours of trade at 8:00 AM on 18 November 2021. Its shares gave a return of 2.44% to shareholders in the last one year, and the market cap stood at £133,071.71 million. 

Also Read: Kape, NCC & Darktrace (DARK): 3 cybersecurity stocks to buy now